1. Home
  2. SRDX vs XPER Comparison

SRDX vs XPER Comparison

Compare SRDX & XPER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • XPER
  • Stock Information
  • Founded
  • SRDX 1979
  • XPER 1990
  • Country
  • SRDX United States
  • XPER United States
  • Employees
  • SRDX N/A
  • XPER N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • XPER Semiconductors
  • Sector
  • SRDX Health Care
  • XPER Technology
  • Exchange
  • SRDX Nasdaq
  • XPER Nasdaq
  • Market Cap
  • SRDX 415.4M
  • XPER 370.5M
  • IPO Year
  • SRDX 1998
  • XPER 2003
  • Fundamental
  • Price
  • SRDX $35.41
  • XPER $5.74
  • Analyst Decision
  • SRDX Buy
  • XPER Strong Buy
  • Analyst Count
  • SRDX 2
  • XPER 3
  • Target Price
  • SRDX $43.00
  • XPER $13.00
  • AVG Volume (30 Days)
  • SRDX 209.2K
  • XPER 373.4K
  • Earning Date
  • SRDX 08-12-2025
  • XPER 08-06-2025
  • Dividend Yield
  • SRDX N/A
  • XPER N/A
  • EPS Growth
  • SRDX N/A
  • XPER N/A
  • EPS
  • SRDX N/A
  • XPER N/A
  • Revenue
  • SRDX $121,575,000.00
  • XPER $488,877,000.00
  • Revenue This Year
  • SRDX N/A
  • XPER $0.50
  • Revenue Next Year
  • SRDX $3.19
  • XPER $8.71
  • P/E Ratio
  • SRDX N/A
  • XPER N/A
  • Revenue Growth
  • SRDX N/A
  • XPER N/A
  • 52 Week Low
  • SRDX $26.00
  • XPER $5.70
  • 52 Week High
  • SRDX $41.32
  • XPER $11.08
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 64.76
  • XPER 15.70
  • Support Level
  • SRDX $34.64
  • XPER $7.56
  • Resistance Level
  • SRDX $38.10
  • XPER $7.59
  • Average True Range (ATR)
  • SRDX 1.48
  • XPER 0.23
  • MACD
  • SRDX 0.20
  • XPER -0.20
  • Stochastic Oscillator
  • SRDX 65.50
  • XPER 1.97

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About XPER Xperi Inc.

Xperi Inc is a consumer and entertainment technology company. Its offering comprises a portfolio of software and services. The company creates extraordinary experiences at home and on the go for millions of consumers around the world, enabling audiences to connect with content in a more intelligent, immersive, and personal way. Its business is divided into four categories based on the products delivered and customers served: Pay-TV, Consumer Electronics, Connected Car, and Platform Solutions. It generates the majority of its revenue from the Consumer Electronics segment. Its also have sales in Japan, Europe and Middle East, China, South Korea, Latin America, and Others.

Share on Social Networks: